Recently, the European Commission (EC) authorized VANFLYTA in combination with standard cytarabine and anthracycline induction therapy, followed by st···【Read More】
Update: 2026-04-10Source: Haiou HealthViews: 107
According to a press release yesterday from Daiichi Sankyo Pharmaceutical Co., Ltd., VANFLYTA (quizartinib) has been launched in the United States. Th···【Read More】
Update: 2026-04-10Source: Haiou HealthViews: 113
Daiichi Sankyo announced on July 20 that the U.S. Food and Drug Administration (FDA) has approved Vanflyta (quizartinib) in combination with standard ···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 114
Yesterday, Daiichi Sankyo Pharmaceutical announced in a press release that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 113
The U.S. FDA has recently accepted and granted priority review to quizartinib's New Drug Application (NDA). The NDA grant is for the treatment of ···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 111
Certain medications should not be used together due to safety concerns. Some drugs can alter blood concentrations of other medications you are taking,···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 112
Grapefruit and grapefruit products may interact with pemigatinib and increase the risk of adverse side effects. Therefore, avoid consuming grapefruit ···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 112
Seek immediate emergency medical help or call the Poison Help hotline.【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 110
Take your dose as soon as you remember. However, if it has been more than 4 hours since your scheduled dose, skip the missed one. Do not take a double···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 106
Pemigatinib demonstrates proven therapeutic activity in patients with previously treated locally advanced/metastatic cholangiocarcinoma and FGFR2 fusi···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 107
While pemigatinib exerts its therapeutic effect, it may cause different types and degrees of side effects due to individual differences in physical co···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 110
Properly understanding the timing of pemitinib administration, dosage adjustment principles, and interactions with food is crucial for improving treat···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 113
FDA Approves Pemigatinib as First-to-Treatment Targeted Therapy for Adult Patients with Previously Treated, Unresectable Locally Advanced or Metastati···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 110
August 26, 2022, Wilmington, Delaware, BUSINESS WIRE.Incyte announced that the U.S. Food and Drug Administration (FDA) has approved pemigatinib® (pemi···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 110
Pemigatinib is developed by Incyte Corporation, USA. In April 2020, the U.S. Food and Drug Administration (FDA) approved pemigatinib for the treatment···【Read More】
Update: 2026-04-09Source: Haiou HealthViews: 113
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos